Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1965 1
1966 3
1967 4
1968 2
1969 2
1970 8
1971 8
1972 5
1973 6
1974 5
1975 5
1976 8
1977 4
1978 5
1979 8
1980 9
1981 3
1982 6
1983 10
1984 4
1985 4
1986 6
1987 5
1988 10
1989 17
1990 15
1991 6
1992 13
1993 11
1994 14
1995 12
1996 18
1997 20
1998 15
1999 16
2000 21
2001 21
2002 12
2003 15
2004 20
2005 35
2006 21
2007 39
2008 27
2009 31
2010 21
2011 21
2012 37
2013 36
2014 39
2015 22
2016 27
2017 41
2018 37
2019 45
2020 25
2021 31
2022 17
2023 16

Text availability

Article attribute

Article type

Publication date

Search Results

868 results

Results by year

Filters applied: . Clear all
Page 1
Tobacco Use and Oral Health.
Ford PJ, Rich AM. Ford PJ, et al. Addiction. 2021 Dec;116(12):3531-3540. doi: 10.1111/add.15513. Epub 2021 Apr 25. Addiction. 2021. PMID: 33822437 Review.
Autotaxin facilitates selective LPA receptor signaling.
Salgado-Polo F, Borza R, Matsoukas MT, Marsais F, Jagerschmidt C, Waeckel L, Moolenaar WH, Ford P, Heckmann B, Perrakis A. Salgado-Polo F, et al. Among authors: ford p. Cell Chem Biol. 2023 Jan 19;30(1):69-84.e14. doi: 10.1016/j.chembiol.2022.12.006. Epub 2023 Jan 13. Cell Chem Biol. 2023. PMID: 36640760 Free article.
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.
Hirani N, MacKinnon AC, Nicol L, Ford P, Schambye H, Pedersen A, Nilsson UJ, Leffler H, Sethi T, Tantawi S, Gravelle L, Slack RJ, Mills R, Karmakar U, Humphries D, Zetterberg F, Keeling L, Paul L, Molyneaux PL, Li F, Funston W, Forrest IA, Simpson AJ, Gibbons MA, Maher TM. Hirani N, et al. Among authors: ford p. Eur Respir J. 2021 May 27;57(5):2002559. doi: 10.1183/13993003.02559-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33214209 Free PMC article. Clinical Trial.
Renaissance in NO Chemistry.
Ford PC, Shiro Y, van Eldik R. Ford PC, et al. Inorg Chem. 2021 Nov 1;60(21):15831-15834. doi: 10.1021/acs.inorgchem.1c03287. Inorg Chem. 2021. PMID: 34724728 No abstract available.
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial.
Maher TM, van der Aar EM, Van de Steen O, Allamassey L, Desrivot J, Dupont S, Fagard L, Ford P, Fieuw A, Wuyts W. Maher TM, et al. Among authors: ford p. Lancet Respir Med. 2018 Aug;6(8):627-635. doi: 10.1016/S2213-2600(18)30181-4. Epub 2018 May 20. Lancet Respir Med. 2018. PMID: 29792287 Free article. Clinical Trial.
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS; ISABELA 1 and 2 Investigators. Maher TM, et al. Among authors: ford p. JAMA. 2023 May 9;329(18):1567-1578. doi: 10.1001/jama.2023.5355. JAMA. 2023. PMID: 37159034
Sanctions on Syria.
Ford P. Ford P. Lancet Glob Health. 2020 Nov;8(11):e1370. doi: 10.1016/S2214-109X(20)30364-8. Epub 2020 Sep 29. Lancet Glob Health. 2020. PMID: 33007215 Free PMC article. No abstract available.
Clinical practice guideline: sudden hearing loss.
Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, Brown SR, Fife TD, Ford P, Ganiats TG, Hollingsworth DB, Lewandowski CA, Montano JJ, Saunders JE, Tucci DL, Valente M, Warren BE, Yaremchuk KL, Robertson PJ; American Academy of Otolaryngology-Head and Neck Surgery. Stachler RJ, et al. Among authors: ford p. Otolaryngol Head Neck Surg. 2012 Mar;146(3 Suppl):S1-35. doi: 10.1177/0194599812436449. Otolaryngol Head Neck Surg. 2012. PMID: 22383545
An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade.
Vuong L, Kouverianou E, Rooney CM, McHugh BJ, Howie SEM, Gregory CD, Forbes SJ, Henderson NC, Zetterberg FR, Nilsson UJ, Leffler H, Ford P, Pedersen A, Gravelle L, Tantawi S, Schambye H, Sethi T, MacKinnon AC. Vuong L, et al. Among authors: ford p. Cancer Res. 2019 Apr 1;79(7):1480-1492. doi: 10.1158/0008-5472.CAN-18-2244. Epub 2019 Jan 23. Cancer Res. 2019. PMID: 30674531
868 results